Heart Valve Disorders and Appetite-Suppressant Drugs

Article Abstract:

Most people who took the diet pills fenfluramine or dexfenfluramine will probably not develop serious heart valve disease. These drugs were withdrawn by the manufacturer in 1997 after the FDA reported an increased risk of heart valve disease in people who took the drugs. A study published in 2000 confirmed this risk, but found that most cases of heart valve disease were mild. Other studies have shown that the heart valves may return to normal when the drugs are discontinued. People who took high doses of the drug for more than three months have the highest risk of valve disease.

Editorial, Complications and side effects, Fenfluramine, Dexfenfluramine, Heart valve diseases

---

Contemporary clinical profile and outcome of prosthetic valve endocarditis

Article Abstract:

A study was conducted to find the characteristics and outcome of prosthetic valve endocarditis (PVE), and to determine prognostic factors associated with in-hospital mortality. It was revealed that PVE accounted for a high percentage of all cases of infective endocarditis in many regions of the world, and complications of PVE strongly predict in-hospital mortality.

United States, Science & research, Research, Diagnosis, Staphylococcal infections, Infective endocarditis, Clinical report

---

Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis

Article Abstract:

Heart valve replacement is more effective than medication for treating a bacterial infection of the heart called endocarditis, according to a study of 513 people. Surgery was especially beneficial for patients with congestive heart failure. Six-month mortality rates were 50% to 80% lower in the patients who had surgery compared with those treated with drugs.

Evaluation, Patient outcomes, Prognosis, Heart valve replacement, Endocarditis

Similar abstracts:

• Abstracts: Differences in generalists' and cardiologists' perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease
• Abstracts: Cancer stem cells: Models and concepts. The biomedical challenges of space flight
• Abstracts: Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization. part 2
• Abstracts: Insomnia in prion diseases: sporadic and familial. Celecoxib for the prevention of sporadic colorectal adenomas
• Abstracts: Preeclampsia, lipid peroxidation, and calcium adenosine triphosphate activity of red blood cell ghosts. Interleukin-18 in the plasma of women with preeclampsia

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.